Efeito da oligofrutose (FOS) sobre a capacidade de acidificação da cultura nativa Lactobacillus plantarum CNPC 003 isolada ou em co-cultura com Streptococcus thermophilus em leite de cabra / Influence of oligofrutose (FOS) on the acidification capacity of the indigenous culture Lactobacillus plantarum CNPC 003 solely or in coculture with Streptococcus thermophilus in goat milk

Objetivou-se analisar o comportamento fermentativo da cultura Lactobacillus plantarum CNPC 003 em leite de cabra em quatro tratamentos por 6 horas: T1 – L. plantarum CNPC 003; T2 – L. plantarum + oliogofrutose (FOS); T3 – L. plantarum + Streptococcus thermophilus; T4 – com L. plantarum + S. thermophilus + FOS. Os tratamentos estudados diferiram significativamente entre si em relação à acidez e ao pH após 6h de fermentação (p<0,05), tendo sido verificada uma influência positiva do uso de S. thermophilus e da adição de FOS sobre esses parâmetros. Do mesmo modo, a presença de FOS melhorou a viabilidade dos microrganismos estudados após 6h de fermentação. A utilização de S. thermophilus e de FOS é uma alternativa viável para o uso em leites fermentados contendo a cepa nativa L. plantarum CNPC 003.

Validation of the Korean coefficient for the modification of diet in renal disease study equation

BACKGROUND/AIMS: Race and ethnicity are important determinants when estimatingglomerular filtration rate (GFR). The Korean coefficients for the isotope dilution mass spectrometry (IDMS) Modification of Diet in Renal Disease (MDRD) Study equations were developed in 2010. However, the coefficients have not been validated. The aim of this study was to validate the performance of the Korean coefficients for the IDMS MDRD Study equations. METHODS: Equation development and validation were performed in separate groups (development group, n = 147 from 2008 to 2009; validation group, n = 125 from 2010 to 2012). We compared the performance of the original IDMS MDRD equations and modified equations with Korean coefficients. Performance was assessed by comparing correlation coefficients, bias, and accuracy between estimated GFR and measured GFR, with systemic inulin clearance using a single injection method. RESULTS: The Korean coefficients for the IDMS MDRD equations developed previously showed good performance in the validation group. The new Korean coefficients for the four- and six-variable IDMS MDRD equations using both the development and validation cohorts were 1.02046 and 0.97300, respectively. No significant difference was detected for the new Korean coefficients, in terms of estimating GFR, between the original and modified IDMS MDRD Study equations. CONCLUSIONS: The modified equations with Korean coefficients for the IDMS MDRD Study equations were not superior to the original equations for estimating GFR. Therefore, we recommend using the original IDMS MDRD Study equation without ethnic adjustment in the Korean population.

Action of phosphorylated mannanoligosaccharides on immune and hematological responses and fecal consistency of dogs experimentally infected with enteropathogenic Escherichia coli strains

The therapeutic action of phosphorylated mannanoligosaccharides (MOS) was investigated regarding its prebiotic activity on enteropathogenic Escherichia coli (EPEC). Diarrhea was induced in dogs by experimental infection with EPEC strains. Then MOS was supplied once a day, in water for 20 days. Immunological (IgA and IgG), hematological (lymphocytes, neutrophils and monocytes) and bacteriological variables (PCR detection of the eae gene of EPEC recovered from stool culture), as well as occurrence of diarrhea were evaluated. All strains caused diarrhea at 24, 48 and 72 h after infection. PCR results indicated that E. coli isolated from stool culture of all infected animals had the eae gene. There was no significant difference among groups as to number of blood cells in the hemogram and IgA and IgG production. MOS was effective in recovering of EPEC-infected dogs since prebiotic-treated animals recovered more rapidly from infection than untreated ones (p < 0.05). This is an important finding since diarrhea causes intense dehydration and nutrient loss. The use of prebiotics for humans and other animals with diarrhea can be an alternative for the treatment and prophylaxis of EPEC infections.

Fructo-oligosaccharide effects on blood glucose: an overview / Efeitos dos fruto-oligossacarídeos no controle glicêmico: revisão

PURPOSE: To identify the current status of scientific knowledge in fructo-oligosaccharides (FOS), non-conventional sugars that play an important role in glycemia control. METHODS: We performed a search for scientific articles in MEDLINE and LILACS databases, from January 1962 to December 2011, using English/Portuguese key words: "blood glucose/glicemia", "prebiotics/prebióticos" and "dietary fiber/fibras na dieta". From an initial number of 434 references, some repeated, 43 references published from 1962 to 2011 were included in this study. The selected texts were distributed in three topics: (1) metabolism of FOS, (2) FOS and experimental studies involving glucose and (3) human studies involving glucose and FOS. RESULTS: Five studies have shown that the use of FOS reduces the fecal content and increases intestinal transit time. Experimental studies have shown that dietary supplementation with high doses (60 g/Kg) of propionate, a short-chain fatty acid decreased glycemia. The use of lower doses (3 g/kg) did not produce the same results. Study in subjects with diabetes type II showed that the addition of 8 grams of FOS in the diet for 14 days, caused a reduction in serum glucose. In another study with healthy subjects, there were no changes in glycemic control. CONCLUSIONS: This review demonstrates that consumption of FOS has a beneficial influence on glucose metabolism. The controversies appear to be due to inadequate methodological designs and/or the small number of individuals included in some studies.

OBJETIVO: Conhecer o estado atual do conhecimento científico em fructooligossacarídeos (FOS), açúcares não-convencionais que desempenham um papel importante no controle da glicemia. MÉTODOS: Realizamos uma busca de artigos científicos nas bases de dados MEDLINE e Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), a partir de janeiro 1962 a dezembro de 2011, usando como descritores termos Português/Inglês: "glicemia/blood glucose, "prebióticos/prebiotics" e "fibras na dieta/dietary fiber. A partir de um número inicial de 434 referências, algumas repetidas, 43 referências foram consideradas adequadas para a finalidade deste estudo e foram, portanto, selecionadas para análise. Os textos selecionados foram distribuídos em três tópicos: (1) metabolismo de FOS (2), FOS e estudos experimentais envolvendo glicose e (3) estudos em humanos envolvendo glicose e FOS. RESULTADOS: Cinco trabalhos mostraram que o uso de FOS diminui o conteúdo fecal e aumenta o tempo do transito intestinal. Estudos experimentais demonstraram que a suplementação dietética com altas doses (60 g/Kg) de propionato, um ácido graxo de cadeia curta, diminuiu a glicemia. A utilização de doses menores (3 g/Kg) não produziu os mesmos resultados. Em indivíduos diabéticos tipo II a adição de 8 g de FOS na dieta, durante 14 dias, induziu uma redução da glicemia. Em indivíduos sadios, não ocorreram alterações da glicemia. CONCLUSÕES: Essa revisão mostra que o consumo de FOS exerce influência benéfica no metabolismo glicêmico. As controvérsias evidenciadas parecem estar mais ligadas a desenhos metodológicos inadequados e/ou ao número reduzido de indivíduos incluídos em alguns estudos.

Influência da dieta com galactooligossacarídeos sobre a absorção de cálcio em ratos normais e gastrectomizados / Dietary galactooligosaccharides increase calcium absorption in normal and gastrectomized rats

OBJETIVO: Verificar se o galactooligossacarídeo estimula a absorção de cálcio em ratos Wistar parcialmente gastrectomizados. MÉTODOS: Os animais foram laparotomizados (controle sham-operado) e parcialmente gastrectomizados (Billroth II) em grupos de 20 e 20 cada, respectivamente. Eles foram alimentados com uma dieta controle (AIN-93M), sem galacto-oligossacarídeo ou uma dieta contendo (galacto-oligossacarídeo - 50g/kg de dieta) durante oito semanas. Os animais foram divididos em quatro subgrupos: sham-operados e não gastrectomizados com galacto-oligossacarídeo, sham-operados e gastrectomizados sem galacto-oligossacarídeo. No dia final do estudo, o sangue total foi coletado para determinação da concentração de cálcio sérico. RESULTADOS: Na dieta no grupo com galacto-oligossacarídeo a excreção do cálcio nas fezes foi significativamente menor do que no grupo sem prebióticos. A absorção aparente de cálcio em ratos gastrectomizados e normais foi maior nos grupos alimentados com galacto-oligossacarídeo do que no grupo com dieta controle. CONCLUSÃO: A dieta com galacto-oligossacarídeos previne a osteopenia em ratos parcialmente gastrectomizados.

OBJECTIVE: To determine whether the galactooligosaccharide stimulates calcium absorption in partially gastrectomized rats. METHODS: Animals were submitted to laparotomy (sham-operated control) and partial gastrectomy (Billroth II) in groups of 20. They were fed a control diet (AIN-93M) without galacto-oligosaccharide or a diet containing (galacto-oligosaccharide - 50g/kg diet) for eight weeks. The animals were divided into four groups: sham-operated and non-gastrectomized with galactooligosaccharide, sham-operated and gastrectomized without galactooligosaccharide. On the final day of the study, whole blood was collected for determination of serum calcium concentration. RESULTS: In the group with galactooligosaccharides calcium excretion in feces was significantly lower than the group without prebiotics. The apparent absorption of calcium in gastrectomized and normal rats was higher in groups fed with galactooligosaccharide than in the control diet group. CONCLUSION: The ingestion of galactooligosaccharides prevents osteopenia in partially gastrectomized rats.

Desenvolvimento de bebidas mistas à base de cajá (Spondias mombin l.) E caju (Anacardium occidentale) enriquecidas com frutooligossacarídeos e inulina / Development of mixed beverages made of caja (Spondias mombin l.) and cashew apple (Anacardium occidentale) added of Fructooligosaccharides and Inulin

O presente trabalho teve como objetivo elaborar tres bebidas mistas a base de caja (Spondias mombin L.) e caju (Anacardium occidentale), na forma "pronto para beber", com propriedades prebioticas e avaliar as suas caracteristicas quimicas, fisico-quimicas e sensoriais. Foram desenvolvidas quatro formulacoes com duas combinacoes de polpa de fruta, sacarose e ingredientes prebioticos (inulina padrao, inulina de alto desempenho- HP e frutooligossacarideos- FOS). As formulacoes foram submetidas as determinacoes de pH, acidez, solidos soluveis, acucares, acido ascorbico, carotenoides totais e polifenois totais e avaliacoes da aceitacao dos atributos sensoriais, corpo, docura e impressao global, atitude de compra e preferencia dos consumidores. Verificou-se que o pH (3,19 a 3,40), solidos soluveis totais (14,80 a 15,40 oBrix) e polifenois totais (24,76 a 34,58mg/100g) apresentaram diferenca estatistica significativa (p .0,01). Enquanto para os teores de acidez total (0,48 a 0,56 mg/100g), acucares totais (7,78 a 9,84%), acucares redutores (1,62 a 2,08%), acucares nao redutores (5,86 a 7,85%), acido ascorbico (33,43 a 35,17 mg/100g) e carotenoides totais (30,30 a 34,20 mg/100g), nao se observou diferenca significativa. Os atributos sensoriais avaliados apresentaram resultados variando na escala sensorial entre "nao gostei nem desgostei" e "gostei muito" (medias de 5,80 a 7,06). Nos atributos docura, corpo e atitude de compra nao houve diferenca (p>0,05) entre as bebidas, porem, diferiram estatisticamente (p.0,05) no atributo impressao global. A bebida com FOS apresentou uma aceitacao semelhante a bebida controle, mostrando ser uma opcao de alimento funcional atendendo as expectativas dos consumidores, que buscam alimentos saudaveis, nutritivos e saborosos.

The purpose of this work was to develop three mixed drinks based on caja (Spondias mombin L.) and cashew apple (Anacardium occidentale) pulps, added prebiotic ingredients and to evaluate their chemical, physicochemical and sensory properties. Four formulations with combinations of two pulp fruit, sucrose and prebiotic ingredients (Standard inulin, inulin high performance-HP-and fructooligosaccharides FOS) were developed. The mixed drinks were submitted the following analysis pH, acidity, soluble solids, sugars, ascorbic acid, total carotenoids, total polyphenols and acceptance ratings of the sensory attributes such as: consistency, sweetness and overall impression, attitude and consumers purchase preference. The pH, total soluble solids and polyphenol results showed difference (p . 0.01) significant, while for the analysis of total acidity, sugars, ascorbic acid and carotenoids, it was not observed significant difference. The sensory attributes evaluates showed results ranging in scale between "I did not like or disliked "and" liked "(average 5.80 to 7.06). The attributes sweetness, consistency and attitude of buying showed no difference (p> 0.05) between drinks, however, differed significantly (p . 0.05) for the attribute of overall impression. The drink with FOS showed a similar acceptance when compared to traditional (sucrose) drink, showing an option of meeting the functional food expectations of consumers, who seek healthy, nutritious and tasty foods.

Barras de amaranto enriquecidas com frutanos: aceitabilidade e valor nutricional / Amaranth bars enriched with fructans: acceptability and nutritional value

Existe uma demanda por alimentos de conveniência com benefícios potenciais à saúde do consumidor. Matérias primas de elevado valor nutritivo e com propriedades funcionais devem ser utilizadas no desenvolvimento desses produtos. O amaranto é um grão de elevado valor nutritivo e isento de glúten. Inulina e oligofrutose são ingredientes prebióticos; que possuem outros efeitos, como o aumento da absorção de cálcio. Barras de amaranto enriquecidas com inulina e oligofrutose foram desenvolvidas nos sabores banana, castanha do Pará e uva passa, coco, damasco, morango e nozes. A composição centesimal foi avaliada e comparada às das barras comerciais, disponíveis nas categorias tradicional (n=59), light (n=60), diet (n=8), à base de soja (n=10) e quinoa (n=1). As barras de amaranto apresentaram média de aceitação global variando de 6,3 a 7,6, numa escala hedônica estruturada de nove pontos, e vantagens nutricionais em relação às barras de cereais comerciais (redução calórica e alto teor de fibras). Apesar de o amaranto ser desconhecido no Brasil, este apresenta bom potencial para o desenvolvimento de alimentos prontos para o consumo. Por serem isentas de glúten estas barras são inclusive uma alternativa para os celíacos, podendo contribuir para o aumento da absorção de cálcio, problema freqüentemente observado nessa população.

There is an increasing appeal for convenience foods with potential health benefits to the consumer. Raw materials with high nutritional value and functional properties must be used on the development of these food products. Amaranth is a gluten-free grain with high nutrition value. Inulin and oligofructose are prebiotic ingredients presenting effects as the enhancement of calcium absorption. Amaranth bars enriched with inulin and oligofructose were developed in the flavors: banana, Brazilian nuts and dried grape, coconut, peach, strawberry and wall nut. The proximate composition were determined and compared to commercial cereal bars, available in traditional (n=59), light (n=60), diet (n=8), with soy (n=10) and quinoa (n=1) categories. Amaranth bars present mean global acceptance values from 6.3 to 7.6 on a 9-point hedonic scale, nutritional advantages as compared to commercial cereal bars (caloric reduction and higher levels of dietary fiber). Although amaranth is an unknown raw material in Brazil, it shows good potential to be used in the manufacturing of ready-to-eat products. As they are gluten free, these amaranth bars are also an alternative product for celiacs, also contributing to the enhancement of calcium absorption, a problem frequently observed in these patients.

Efeito bifidogênico do frutooligossacarídeo na microbiota intestinal de pacientes com neoplasia hematológica / Bifidogenic effect of fructooligosaccharides in the intestinal flora of patients with hematological neoplasia

OBJETIVO: Verificar o efeito bifidogênico do frutooligossacarídeo nos pacientes com neoplasias hematológicas submetidos a quimioterapia. MÉTODOS: Trata-se de um estudo clínico randomizado duplo cego, desenvolvido na Unidade de Transplante de Medula Óssea do Centro de Pesquisas Oncológicas de Florianópolis, o qual envolve 25 pacientes divididos em 2 grupos que receberam, por 15 dias, 12g de frutooligossacarídeo (n=14) ou placebo (maltodextrina) (n=11). Foram avaliados a quantidade de bifidobactérias e os valores de pH fecal antes e após a suplementação. RESULTADOS: Observou-se na população estudada o predomínio do sexo masculino (72 por cento) e a idade média de 34 anos. O grupo suplementado apresentou um aumento significante na quantidade de bifidobactérias (p<0,05) e o pH fecal não foi alterado em nenhum dos grupos. CONCLUSÃO: Verificou-se que a suplementação aumentou a quantidade de bifidobactérias, interferindo na composição da microbiota intestinal, e que não houve alteração do pH fecal.

OBJECTIVE: To verify the bifidogenic effect of fructooligosaccharides in patients with hematological neoplasia submitted to chemotherapy. METHODS: This is a clinical, randomized, double-blind study done in the Bone Marrow Transplant Unit of the Oncology Research Center of Florianopolis. It involved 25 patients divided into 2 groups who received 12g of fructooligosaccharides (n=14) for 15 days or placebo (maltodextrin) (n=11). The amount of bifidobacteria and the values of fecal pH before and after supplementation were investigated. RESULTS: Most of the studied population was male (72 percent) and the mean age was 34 years. The group that received supplementation presented a significant increase in the amount of bifidobacteria (p<0.05) and fecal pH remained unchanged in both groups. CONCLUSION: Supplementation increased the amount of bifidobacteria, interfering in the composition of the intestinal flora, but fecal pH was not affected.

Use of mannanoligosacharides as an adjuvant treatment for gastrointestinal diseases and this effects on E. coli inactivated in dogs

PURPOSE: To evaluate the effects of mannanoligosacharides on dogs showing gastroenteritis. METHODS: Sixteen dogs, 2-6 month-old, distributed into two groups: T1 - animals with gastroenteritis receiving treatment for the disease + mannanoligosacharides (2 g/animal).; and T2 - animals with gastroenteritis receiving just treatment for the disease. The animals were randomly included in the sample and all of them were submitted to blood and feces collection for coproculture. In the treatment for gastroenteritis antibiotic, antihemetic, vermifuge, vitamins and sorotheraphy were used. The parameters evaluated were the numbers of leucocytes, neutrophils, lymphocytes and the presence of enteropathogenic bacteria in feces. RESULTS: The mannanoligosacharides was effective in eliminating pathogenic E. coli in 85.71 percent of the animals, while in the no-treated group only 25 percent of the animals were negative to E. coli. CONCLUSION: The mannanoligosacharides is effective in the control of pathogenic E. coli and it can be indicated as an adjuvant treatment for gastroenteritis in dogs.

OBJETIVO: Avaliar os efeitos da adição de mananoligossacarídeos fosforilados (MOS) que apresentavam gastroenterite , pacientes de uma Clínica Veterinária. MÉTODOS: foram estudados 16 cães de 2 a 6 meses de idade, de várias raças. Os animais foram distribuídos em 2 grupos, sendo o grupo T1 composto por animais com gastroenterite, que receberam o tratamento para a doença e Mos (2,0 g/animal) e o grupo T2, animais com gastroenterite, que somente receberam o tratamento para a doença sem o MOS. Os animais foram incluídos aleatoriamente na amostra e todos eles foram submetidos à coleta de sangue e de fezes para coprocultura.O tratamento para a gastroenterite constituiu-se de antibiótico,antiemético,vermífugo,vitaminas e soroterapia. No experimento, foram avaliados os leucócitos, neutrófilos, linfócitos e a presença de bactérias enteropatogênicas nas fezes. RESULTADOS: Constatou-se a efetividade do Mos no grupo tratado, quando houve a eliminação da Escherichia coli patogênica em 85,71 por cento dos animais,enquanto que, no grupo sem o Mos, só 25 por cento, não apresentaram o microorganismo. CONCLUSÃO: O Mos é efetivo no controle da E. coli patogênica, sendo indicado como tratamento adjuvante nas gastroenterites.

Fructooligosacáridos en el organismo / Fructo-oligosaccharides in organism

Los FOS son carbohidratos indigeribles que estimulan selectivamente el crecimiento de bifidobacterias. Se encuentran naturalmente en alimentos como la banana, ajo, alcaucil, achicoria y tomate, entre otros. Escapan a la digestión de enzimas pancreáticas e intestinales, llegando al colon donde son fermentados por la microflora colónica, produciéndose ácidos grasos de cadena corta (acetato, butirato y propionato). El consumo de FOS produce diversos efectos beneficiosos sobre la salud, entre los que se incluyen la proliferación de bifidobacterias y la reducción de la concentración de bacterias patógenas en el colon; como así también la concentración de metabolitos tóxicos y enzimas perjudiciales, mejora la microflora intestinal, previene la constipación, la diarrea; mejora la inmunidad; posee un efecto antimicrobiano y anticancerígeno y mejora la absorción de minerales. En la actualidad se encuentra en discusión los efectos sobre los lípidos séricos y la glucemia. Uno de los efectos adversos es la producción de gases a dosis mayores de 40 gramos por día. Los FOS pueden ser producidos industrialmente, uno de los métodos es por acción de la enzima fructofuranosidasa, aislada a partir del Aspergillus Niger, sobre la sacarosa. Futuros estudios en humanos brindarán nueva información sobre la utilización de FOS de manera profiláctica en diversas enfermedades...

Oligosaccharide and creatine supplementation on glucose and urea nitrogen in blood and serum creatine kinase in basketball athletes / 华中科技大学学报（医学）（英德文版）

The effects of oligosaccharide and creatine (Cr) supplementation on glucose, lactic acid and urea nitrogen levels in blood and activity of serum creatine kinase (CK) were explored. Twenty CUBA male athletes were divided into 4 groups: group A (supplementation of Cr alone), group B (supplementation of oligosaccharide), group C (supplementation of oligosaccharide and Cr) and group D (placebo control group). By using orthogonal L4 table (2(3)), the experiment was performed. There were factors including oligosaccharide (carbohydrate, CHO), Cr and their correlation. Each factor had two levels: supplementation and no-supplementation. The results showed that the supplementation of CHO or Cr alone, combined supplementation of CHO and Cr could significantly reduce the glucose, urea nitrogen levels in blood and serum CK activity after competition in the athletes. Moreover, the effects of combined supplementation of CHO and Cr were more satisfactory. It was concluded that supplementation of CHO and Cr could promote the recovery of physical performance and athletic abilities after athletics in basketball athletes.

Short-chain oligosaccharide protein conjugates as experimental pneumococcal vaccines.

Streptococcus pneumoniae remains a major cause of acute respiratory infections worldwide and is responsible for approximately 1 million childhood deaths each year. Despite the widespread use of antibiotics, the mortality and morbidity of pneumococcal disease remains high. Therefore, effective vaccines to prevent pneumococcal disease are needed. Bacterial vaccine development in general follows a similar track starting from large, rather crude vaccines (whole live, attenuated pathogen) towards smaller, better defined subunit vaccines. Ultimately, this track leads to the development and evaluation of minimal, highly defined subunit vaccines, based on a collection of single protective epitopes. This mini-review deals with capsular saccharide based vaccines. After a short overview of the development of pneumococcal vaccines from the 23 - valent polysaccharide vaccines to polysaccharide-protein conjugate vaccines, it focuses on the vaccine potential of synthetic oligosaccharides, conjugated to carrier proteins.